Could a new pill ease depression linked to early life trauma?
NCT ID NCT07369115
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if the drug lumateperone can reduce depression symptoms in adults aged 21 to 70 who have major depressive disorder and a history of early life trauma. Half of the 50 participants will get the drug, and half will get a placebo, with results measured after 6 weeks. The goal is to see if the drug is safe and effective for this specific group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY LIFE TRAUMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Health Discovery Building
Austin, Texas, 78701, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital sleep and mood programs put to the test for breast cancer survivors
- Antidepressants may rewire how the brain perceives control
- Brain scans may predict which kids respond to family therapy for depression
- Could a group therapy tackle both depression and anxiety in teens?
- What makes therapy work? study digs into the 'How' of treating anxious and depressed kids
- Brain zaps and mindfulness: a new hope for veterans in pain?